7,718.60

-29.11

-0.38%

53,414.25

-271.86

-0.51%

26,506.99

-77.11

-0.29%

2,975.65

+7.38

+0.25%

14.53

+0.21

+1.47%

4,476.60

-63.30

-1.39%

79,635.00

-1,406.79

-1.74%

Crude Oil Oct 26

91.48

+0.18

+0.20%

Summit Packs A Punch For Merck's Keytruda — But Not Everyone Is Sold

Summit Packs A Punch For Merck's Keytruda — But Not Everyone Is Sold · Investor's Business Daily

ALLISON GATLIN

Thu, September 3, 2026 at 4:51 PM EDT 3 min read

Summit Therapeutics stock rocketed Thursday after its experimental cancer drug outperformed Merck's blockbuster, Keytruda.

Continue Reading

Terms and Privacy Policy

Your Privacy Choices

Mobilize your Website

View Site in Mobile | Classic

Share by: